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MICRONEEDLE DEVICE FOR 
EXTRACTION AND SENSING OF BODILY 
FLUIDS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation-in-part of U.S. patent 
application Ser. No. 09/316,229, now U.S. Pat. No. 6,334, 
856, filed May 21, 1999, which is a continuation-in-part of 10 
U.S. patent application Ser. No. 09/095,221, now U.S. Pat. 
No. 6,503,231, filed Jun. 10, 1998. This application claims 
the benefit of the filing date of U.S. provisional application 
Ser. No. 60/146,200, filed Jul. 29, 1999. 
2 
SUMMARY OF THE INVENTION 
Microneedle devices for controlled sampling of biological 
fluids in a minimally-invasive, painless, and convenient 
manner, are provided. The microneedle devices permit in 
vivo sensing or withdrawal of biological fluids from the 
body, particularly from or through the skin or other tissue 
barriers, with minimal or no damage, pain, or irritation to the 
tissue. 
The microneedle device includes one or more micron-
eedles, preferably in a three-dimensional array, a substrate to 
which the microneedles are connected, and at least one 
collection chamber and/or sensor in communication with the 
microneedles. Preferred embodiments further include a 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
This invention was made with govermnent support under 
Contract Number BES-9813321 awarded by the U.S. 
National Science Foundation. The government has certain 
rights in the invention. 
15 means for inducing biological fluid to be drawn through the 
microneedles and into the collection chamber for analysis. 
In a preferred embodiment, this induction is accomplished 
by use of a pressure gradient, which can be created for 
example by selectively increasing the interior volume of the 
20 collection chamber, which includes an elastic or movable 
portion engaged to a rigid base. 
BACKGROUND OF THE INVENTION 
This invention is generally in the field of devices for the 
withdrawal and sensing of biological fluids, such as in the 
analysis of blood glucose levels. 
In a preferred embodiment, the microneedle device fur-
ther comprises means for transduction, storage, transmis-
sion, and display of measured values. The microneedle 
25 device also preferably includes means for securing the 
device to a biological barrier during withdrawal or sensing. 
Preferred biological fluids for withdrawal and/or sensing 
include blood, lymph, interstitial fluid, and intracellular 
fluid. Examples of analytes in the biological fluid to be 
The extraction of analytes through the skin is critical to 
diabetic patients, who typically must measure blood glucose 
several times per day in order to optimize insulin treatment 
and thereby reduce the severe long-term complications of 
the disease. Currently, diabetics do this by pricking the 
highly vascularized fingertips with a lancet to perforate the 
skin, then milking the skin with manual pressure to produce 
30 measured include glucose, cholesterol, bilirubin, creatine, 
metabolic enzymes, hemoglobin, heparin, clotting factors, 
uric acid, carcinoembryonic antigen or other tumor antigens, 
reproductive hormones, oxygen, pH, alcohol, tobacco 
metabolites, and illegal drugs. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 is a cross-sectional view of a preferred embodi-
ment of a microneedle device for fluid withdrawal. 
FIG. 2 is a cross-sectional view of another preferred 
embodiment of a microneedle device for fluid withdrawal. 
a drop of blood, which is then assayed for glucose using a 35 
disposable diagnostic strip and a meter into which the strip 
fits. This method of glucose measurement has the major 
disadvantage that it is painful, so diabetics do not like to 
obtain a glucose measurement as often as is medically 
indicated. It would therefore be highly useful to be able to 40 
obtain a sample of blood, lymph, or interstitial fluid more 
quickly, using an easier procedure, and relatively noninva-
sively. It also would be advantageous to be able to repeat-
edly or continually extract analyte transdermally over a 
period of time. 
Another common technique for withdrawal of bodily 
fluids, such as for diagnostic purposes, is the use of a needle, 
such as those used with standard syringes or catheters. While 
effective for this purpose, needles are invasive and generally 
cause pain; local damage to the skin at the site of insertion; 50 
and bleeding, which can increase the risk of disease trans-
mission. Needle techniques also generally require adminis-
tration by one trained in its use, and are not preferred for 
frequent routine use due to the vascular damage caused by 
repeated punctures. Some proposed alternatives to the 55 
needle require the use of (1) lasers or heat to create a hole 
FIGS. 3a-c are cross-sectional views of preferred embodi-
ments of a microneedle device in which a sensor is included 
on the external surface of a hollow needle (3a ), on the 
45 internal bore surface of a hollow needle (3b ), and within the 
pores of a porous, hollow needle (3c). 
in the skin, which is inconvenient, expensive, or undesirable 
for repeated use; (2) electric fields or ultrasound, which also 
is inconvenient and expensive; or (3) chemical or biological 
penetration enhancing agents, which can be irritating to the 60 
tissue and undesirable for repeated use. 
It is therefore an object of the present invention to provide 
a device for controlled sampling of biological fluids in a 
minimally-invasive, painless, and convenient mamier. 
It is another object of the present invention to provide a 65 
device for sensing of biological fluids in a minimally-
invasive, painless, and convenient manner. 
FIG. 4 is cross-sectional view of a preferred embodiment 
of a microneedle device connected to a standard-type 
syringe. 
FIGS. Sa-e are side cross-sectional views of a method for 
making microneedles. 
FIGS. 6a-g are side cross-sectional views of a method for 
making a hollow microneedle. 
FIGS. 7a-d are side cross-sectional views illustrating a 
preferred method for making hollow microneedles. 
FIGS. Sa-d are side cross-sectional views illustrating a 
preferred method for making hollow silicon microtubes. 
FIGS. 9a-e are side cross-sectional views illustrating a 
preferred method for making hollow metal microtubes. 
FIGS. lOa-d are side cross-sectional views illustrating a 
preferred method for making tapered metal microneedles. 
FIGS. lla-d are side cross-sectional views illustrating a 
method for making tapered microneedles using laser-formed 
molds. 
FIGS. 12a:f are side cross-sectional views illustrating a 
second method for making tapered microneedles using laser-
formed molds. 
US 7,344,499 Bl 
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DETAILED DESCRIPTION OF THE 
INVENTION 
1. The Microneedle Device 
The microneedle devices include at least three compo-
nents: at least one, preferably more, microneedle(s), a sub-
strate to which the base of the microneedle(s) is secured or 
integrated, and at least one fluid collection chamber and/or 
sensor that is selectably in communication with at least one 
microneedle. Typically, the microneedles are provided as a 
three-dimensional array, in contrast to a device with a single 
needle or row of needles. The microneedle device can be 
adapted to be a single-use, disposable device, or can be 
adapted to be fully or partially reusable. 
a. Substrate 
4 
conduit for the collection of biological fluid, while being 
inserted into the skin, while remaining in place for up to a 
number of days, and while being removed. In embodiments 
where the microneedles are formed of biodegradable poly-
mers, the microneedle must remain intact at least long 
enough for the microneedle to serve its intended purpose 
(e.g., its conduit function). The microneedles should be 
sterilizable using standard methods, such as ethylene oxide 
treatment or gamma irradiation. The microneedles can have 
10 straight or tapered shafts. A hollow microneedle that has a 
substantially uniform diameter, which needle does not taper 
to a point, is referred to herein as a "microtube." As used 
herein, the term "microneedle" includes both microtubes 
and tapered needles unless otherwise indicated. In a pre-
15 ferred embodiment, the diameter of the microneedle is 
greatest at the base end of the microneedle and tapers to a 
point at the end distal the base. The microneedle can also be 
fabricated to have a shaft that includes both a straight 
The substrate of the device can be constructed from a 
variety of materials, including metals, ceramics, semicon-
ductors, organics, polymers, and composites. The substrate 
includes the base to which the microneedles are attached or 20 
integrally formed. A fluid collection chamber and/or sensor 
can be attached to the substrate or formed (e.g., as part of the 
substrate) to communicate directly with the base of the 
microneedles. 
(untapered) portion and a tapered portion. 
The microneedles can be formed with shafts that have a 
circular cross-section in the perpendicular, or the cross-
section can be non-circular. For example, the cross-section 
of the microneedle can be polygonal (e.g. star-shaped, 
square, triangular), oblong, or another shape. The shaft can 
b. Microneedles 
The microneedles function either as a conduit, a sensing 
element, or a combination thereof. Conduit microneedles 
can have a porous or hollow shaft. As used herein, the term 
"porous" means having pores or voids throughout at least a 
portion of the microneedle structure, sufficiently large and 
sufficiently interconnected to permit passage of fluid and/or 
solid materials through the microneedle. As used herein, the 
term "hollow" means having one or more substantially 
annular bores or channels through the interior of the micron-
eedle structure, which have a diameter sufficiently large to 
permit passage of fluid and/or solid materials through the 
microneedle. The annular bores may extend throughout all 
or a portion of the needle in the direction of the tip to the 
base, extending parallel to the direction of the needle or 
branching or exiting at a side of the needle, as appropriate. 
A solid or porous microneedle can be hollow. One of skill in 
the art can select the appropriate porosity and/or bore 
features required for specific applications. For example, one 
can adjust the pore size or bore diameter to permit or 
regulate passage of the particular material to be transported 
through the microneedle device. 
In one embodiment, one or more of the microneedles are 
coated (if solid, porous, or hollow) and/or at least partially 
filled (if porous or hollow) with a sensing or diffusion-
modifying material. 
The microneedles of the device can be constructed from 
a variety of materials, including metals, ceramics, semicon-
ductors, organics, polymers, and composites. Preferred 
materials of construction include pharmaceutical grade 
stainless steel, gold, titanium, nickel, iron, tin, chromium, 
copper, palladium, platinum, alloys of these or other metals, 
silicon, silicon dioxide, and polymers. Representative bio-
degradable polymers include polymers of hydroxy acids 
such as lactic acid and glycolic acid polylactide, polygly-
colide, polylactide-co-glycolide, and copolymers with PEG, 
polyanhydrides, poly( ortho )esters, polyurethanes, poly(bu-
tyric acid), poly(valeric acid), and poly(lactide-co-caprolac-
tone ). Representative non-biodegradable polymers include 
polycarbonate, polymethacrylic acid, ethylenevinyl acetate, 
polytetrafluoroethylene (TEFLOWM), and polyesters. 
The microneedles should have the mechanical strength to 
remain intact for sensing analyte and/or for serving as a 
25 have one or more bores. The cross-sectional dimensions 
typically are between about 1 µm and 500 µm, and prefer-
ably between 10 µm and 100 µm. The outer diameter is 
typically between about 10 µm and about 100 µm, and the 
inner diameter is typically between about 3 µm and about 80 
30 µm. 
The length of the microneedles typically is between about 
10 µm and 1 mm, preferably between 100 µm and 500 µm, 
and more preferably between 150 µm and 350 µm. The 
length is selected for the particular application, accounting 
35 for both an inserted and uninserted portion. An array of 
microneedles can include a mixture of microneedles having, 
for example, various lengths, outer diameters, inner diam-
eters, cross-sectional shapes, and spacings between the 
microneedles. Preferably, the microneedles are sized to 
40 avoid or minimize contact with nerve endings in the bio-
logical tissue, such as the dermis, thereby eliminating or 
reducing pain when the microneedles are inserted, for 
example into the skin. 
The microneedles can be oriented perpendicular or at an 
45 angle to the substrate. Preferably, the microneedles are 
oriented perpendicular to the substrate to provide structural 
strength and to permit ease of insertion into the tissue. An 
array of microneedles can include a mixture of microneedle 
orientations, heights, spacings, or other parameters. This 
50 variation in an array can be useful, for example, if different 
microneedles are to provide different sensing or insertion 
functions. 
In one embodiment, the microneedle has one or more 
holes (ports) or slits positioned on the sides of the shaft of 
55 a hollow microneedle having a blunt, open, or closed tip. 
This design may reduce blockage of the conduit, for 
example, due to tissue or cells when the microneedles are 
inserted. 
In a preferred embodiment of the device, the substrate 
60 and/or microneedles, as well as other components, are 
formed from flexible materials, or have appropriate materi-
als so as to be flexible, to allow the device to fit the contours 
of the biological barrier, such as the skin, vessel walls, or the 
eye, to which the device is applied. A flexible device 
65 facilitates more consistent penetration during use, since 
penetration can be limited by deviations in the attachment 
surface. For example, the surface of human skin is not flat 
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due to dermatoglyphics (i.e. tiny wrinkles) and hair. Con-
formality of the flexible device to the skin can be further 
enhanced by using an external force, such as a uniform 
pressure, to aid insertion of the microneedles into the 
biological barrier. 
c. Collection Chamber 
The fluid collection chamber is selectably in connection 
with the microneedle bores or pores, such that a biological 
fluid can flow from the tissue surrounding the microneedle, 
through the microneedle, and into the collection chamber. 10 
Typically, the collection chamber is attached to, or inte-
grated into, the substrate. The chamber should function to 
contain a biological fluid sample so as to permit analysis 
within the microneedle device or following transfer to a 
separate analytical device. 15 
The collection chamber can be substantially rigid or 
readily deformable. The collection chamber can be formed 
from one or more polymers, metals, ceramics, semiconduc-
tor, or combinations thereof. In a preferred embodiment, the 
collection chamber contains a porous or absorbent material, 20 
such as a sponge, gel, or paper or polymeric strip. The 
material can be permanently contained or removable, and 
can function as a diagnostic element or substrate for use in 
analytical devices. The chamber can initially be empty or 
can contain a gas or one or more reagents in any form (e.g., 25 
liquid or solid particles). In one embodiment, at least a 
portion of the interior walls of the chamber are coated with 
a reagent for assaying the biological fluid. 
In a preferred embodiment, the collection chamber is 
formed of an elastic material, such as an elastomeric poly- 30 
mer or rubber. For example, the collection chamber can be 
a collapsed balloon-like pouch that expands when the bio-
logical fluid is drawn into the collection chamber. 
6 
includes substrate 12 from which a three-dimensional array 
of microneedles 14 protrude. As shown, the annular bore of 
the microneedles 14 extends through the substrate 12. The 
device 10 also includes fluid collection chamber 16 which is 
in fluid connection with the microneedles 14. Fluid collec-
tion chamber 16 includes an access port 18 through which 
collected fluid can be withdrawn from collection chamber 
16, and/or through which a withdrawing force, such as a 
vacuum, can be applied. In FIG. 2, microneedle device 20 
includes substrate 12 from which a three-dimensional array 
of microneedles 14 protrude, and fluid collection chamber 
16, as well as elastic cap 22 and one-way valve 24. The 
interior of elastic cap 22 is in communication with, or open 
to, fluid collection chamber 16. 
d. Sensors 
The sensing/analyzing function can occur in the micron-
eedle or body of the device (e.g., in the fluid collection 
chamber), or external to the device following removal of a 
sample. The sensing device can be in or attached to one or 
more microneedles, integrated into the substrate, or within 
or in communication with the fluid collection chamber. 
Bio sensors can be located on the microneedle surface, inside 
a hollow or porous microneedle, or inside a device in 
communication with the body tissue via the microneedle 
(solid, hollow, or porous). 
In a preferred embodiment, the microneedle device pro-
vides a single-use collection means. In this design, the 
microneedle array is used to extract a single measurement 
and then is detached from a reusable base portion, if any, and 
disposed. 
In one embodiment, the microneedle device is adapted to 
work with "laboratory-on-a-chip" devices, such as manu-
factured by Caliper Technologies, Palo Alto, Calif. (see, e.g., 
U.S. Pat. No. 5,852,495 to Paree and U.S. Pat. No. 5,876,675 The collection chamber of a microneedle device can 
include a plurality of compartments that are temporarily or 
permanently isolated from one another and/or from a portion 
of the microneedles in an array. The device can, for example, 
be provided to collect or sense through different needles at 
different rates or at different times into the different com-
35 to Kennedy); Aclara Biosciences, Hayward, Calif. (see, e.g., 
U.S. Pat. No. 5,858,188 to Soane et al. and U.S. Pat. No. 
5,883,211 to Sassi et al.); and Nanogen, San Diego, Calif. 
(see, e.g., U.S. Pat. Nos. 5,605,662 and 5,632,957 to Heller 
et al.). 
(i). Tapes of Sensors 
Useful sensors may include sensors of pressure, tempera-
ture, chemicals, pH, and/or electro-magnetic fields. These 
microneedle biosensors can include four classes of principal 
transducers: potentiometric, amperometric, optical, and 
partments. Alternatively, some of the different compart- 40 
ments can contain analytical reagents which can be com-
bined with the biological fluid sample, for example, by 
piercing, or otherwise removing, a barrier between the 
compartments, so as to allow the materials to mix for 
analysis. 45 physiochemical. An amperometric sensor monitors currents 
generated when electrons are exchanged between a biologi-
cal system and an electrode. Blood glucose sensors fre-
quently are of this type. 
In a preferred embodiment, the collection chamber is a 
standard or Luer-Lock syringe adapted to be connected to a 
microneedle array. See FIG. 4 which illustrates a preferred 
embodiment wherein device 220 includes substrate 212 
from which a three-dimensional array of microneedles 214 
protrude. The device 220 also includes plunger 222 that is 
slidably secured to the upper surface of substrate 212 by 
plunger guide frame 224 using a restraint such as a Luer-
lock interface 223. The substrate 212 can be attached or 
detached to a syringe 226 via a connector such as a Luer-
lock type attachment 223. The plunger 222, guide frame 
(outer syringe housing) 224, and connector 223 connect to, 
form or contain reservoir 216. A Luer-lock type attachment 
alternatively may be used to secure the device to means, 
such as a pump, for controlling flow or transport through the 
device. 
In another preferred embodiment, the collection chamber 
is adapted to receive and use standard glucose sensing strips, 
which can be loaded into the microneedle device before, 
during, or after the biological fluid is extracted. 
Preferred embodiments of the microneedle device are 
shown in FIGS. 1-2. In FIG. 1, microneedle device 10 
Sensing information or signals can be transferred opti-
50 cally (e.g., refractive index) or electrically (e.g., measuring 
changes in electrical impedance, resistance, current, voltage, 
or combination thereof). For example, it may be useful to 
measure a change in the resistance of tissue to an electrical 
current, wherein different resistances are calibrated to signal 
55 that withdrawal has been completed. 
In a preferred embodiment, the microneedle device may 
include an integrated sensor, such as a chemical sensor, 
biosensor, or other measurement system to form a complete 
extraction/measurement system. The unit can be constructed 
60 to function as a closed loop drug delivery unit, including 
drug delivery means, analyte recovery means, sensing 
means to measure the analyte, and control means to provide 
a signal to the drug delivery means. In a preferred embodi-
ment, the unit would include subunits to withdraw fluid and 
65 calculate the concentration of glucose, for example, to 
determine the amount of insulin needed and deliver that 
amount of insulin. 
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The device can include means for assaying the amount of 
analyte extracted. For example, an assay method that results 
in a color change could be used. The change in color could 
be detected using a light beam that enters into a disposable 
collection chamber through a window on top. The analyte 
may also be detected in the chamber through the use of an 
enzyme electrode or biosensor. The analyte sensing system 
can include enzymes that react with the analyte of interest 
and either electrochemical or optical transducers that mea-
sure the content of reaction. Examples of such enzymes are 10 
glucose oxidase and glucose dehydrogenase. 
An example of an enzyme electrode for glucose is a 
screen-printed electrode on the surface of which is immo-
bilized glucose oxidase and an electron mediator such as 
ferrocene or its derivatives. Electrons generated by the 15 
oxidation of glucose are transferred from glucose oxidase to 
the electrode via the mediator. Thus, the concentration of 
glucose in the analyte solution is proportional to the current 
generated. Yet another detection mechanism may be used 
based on near-infrared spectroscopy. In this method, con- 20 
centration of extracted glucose in a gel is detected by the 
absorption of the near-infrared light that passes through the 
chamber through two windows. 
(ii). Microneedle as Sensing Element 
In one embodiment, the microneedle is adapted to be the 25 
sensing element. For example, an assay material, such as 
glucose oxidase, can be (i) coated onto the external surface 
of hollow or solid microneedles, (ii) distributed within the 
pores of porous microneedles, or (iii) line or fill the bore(s) 
of hollow microneedles. See FIG. 3 which illustrates a cross 30 
sectional view of a preferred embodiment of a microneedle 
device 30 including microneedle 32, attached to substrate 34 
and having hollow bore 36. In FIG. 3a, sensor material 38 
8 
sensed data, for example, to average measured values or 
eliminate outlying datapoints so as to provide more useful 
measurements. 
The electronics package also can include software and 
hardware to initiate or automate the sensing and analysis 
processes. It may be desirable to design a microneedle 
device capable of taking multiple measurements to with-
draw/sense samples on a preprogrammed schedule (e.g., 
periodic or random), for example, to monitor the blood 
plasma levels of an illegal drug. Such a device could be 
adapted for use with a transmitter designed to lock onto the 
wrist or ankle of a drug offender or other probationer. The 
device would then be able to randomly test the wearer 
without his knowledge in order to assess his compliance 
with orders to abstain from drug or alcohol use. 
In an alternative embodiment, the electronics package 
includes a device for controlling the withdrawal or sensing 
process. For example, sensing could be activated based on 
elapsed time, body temperature, or in response to an external 
trigger (e.g., motion sensor or push-button). The electronics 
package, for example, could provide substantially instanta-
neous readings of glucose levels by depressing a button, or 
in a microneedle device (e.g., adapted to be worn for an 
extended period of time), the electronics could it could 
display a s=ary of intermittent glucose measurements 
taken automatically throughout the day. Such a microneedle 
device would be highly useful to diabetic patients to rou-
tinely monitor their blood glucose levels following insulin 
dosing, between or following meals, and at other times 
throughout the day. 
(iv). Single Unit Multiple Sensing 
A single microneedle device can be designed to provide 
multiple, preferably sequential, measurements. In a pre-
ferred embodiment, the device includes a plurality of dis-is coated on the external surface of microneedle 32. In FIG. 
3b, sensor material 38 is coated on the internal surface of 
hollow bore 36. In FIG. 3c, sensor material 38 is located 
within the pores of a porous microneedle 32. Solid micron-
eedles can also hold or contain sensor material as in FIG. 3a, 
or as in FIG. 3c if the microneedles are porous. These 
various microneedle types and sensors can be used in 
different combinations within a device array. 
35 crete fluid collection chambers, each of which is in com-
munication with a defined subset of microneedles in an array 
of microneedles. The sensing unit of the device can sense 
each of the collection chambers independently. The sensing 
can be triggered manually or device electronics can be 
In this embodiment, the assay material contacts the ana-
lyte for which it is selective and undergoes a change, such 
40 preprogranimed to automatically trigger, for example at 
specific time intervals. The device can include a means for 
storing, displaying, or transmitting the multiple measured 
values as needed. 
as an oxidation reaction. This change is communicated, 45 
either directly or indirectly, to the user. For example, change 
may be indicated optically (change in color or refractive 
index) or electrically. Alternatively, the change may induce 
(v). Sensor Calibration 
Calibration of the sensor can be accomplished using the 
concentration of a second analyte or the same analyte 
measured by another means. The primary analyte can be 
normalized, lowering extraction to extraction and site to site 
variability, by the concentration of the second analyte or a shift in pH that can be measured and communicated using 
conventional techniques. In more complex embodiments, 
the analyte may be adsorbed to the microneedle or a coating 
thereon, such that mechanical sensing can be used, for 
example, by measuring vibration changes caused by the 
adsorption. 
(iii). Sensor Electronics 
In a preferred embodiment, the sensors are selectively in 
communication with an electronics package. The electronics 
package typically includes a power source (e.g., a battery), 
as well as electronic hardware and software for the trans-
duction, storage, transmission, and display of measured 
values. The electronics package can be selectively fixed to 
the microneedle device, for example, so that the electronics 
package can be reused with a new, disposable microneedle 
device. The electronics package can include a mechanism 
for wireless or wire-based transmission of measured values 
to a remote device for analysis and/or display. The electron-
ics also may include mathematical manipulation of the 
50 same analyte from a separate measurement. Normalization 
may be a linear or non-linear relationship. 
In a preferred embodiment for glucose sensing, a reusable 
sensor, which assays glucose concentration in interstitial 
fluid, can be calibrated daily by correlating interstitial fluid 
55 glucose values with values obtained from glucose measure-
ments obtained from blood, similar to the approach used by 
Cygnus Inc.'s "Gluco-Watch." 
e. Attachment Feature 
In a preferred embodiment, the microneedle device 
60 includes an adhesive material to secure the microneedle 
device to the skin, temporarily immobilizing the micron-
eedles while inserted into the skin to sense or withdraw fluid. 
The adhesive agent typically is applied to the substrate (in 
between the microneedles at their base) or to an attachment 
65 collar or tabs adjacent the microneedles. 
Care must be taken so that any adhesive agent does not 
plug the bores of hollow microneedles. For example, the 
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adhesive agent can be applied in a liquid solution by 
flooding the top of the substrate below the tips of the 
microneedles, such as from the side of an array of micron-
eedles, or by using a three-dimensional printing process or 
spin coating. The solvent can then be evaporated from the 
adhesive agent solution, thereby precipitating or gelling the 
adhesive agent to yield a tacky surface. An alternate method 
10 
cation (SPIE Optical Engineering Press, Bellingham, Wash. 
1997); and Madou, Fundamentals of Microfabrication 
(CRC Press 1997). 
The following methods are preferred for making micron-
eedles. 
(i). Electrochemical Etching of Silicon 
of keeping the tips free of an applied adhesive agent is to 
choose materials of construction having a hydrophobicity or 
hydrophilicity to control the wetting of the surface to the 10 
microneedle tips. 
In this method, electrochemical etching of solid silicon to 
porous silicon is used to create extremely fine (on the order 
of0.01 µm) silicon networks which can be used as piercing 
structures. This method uses electrolytic anodization of 
silicon in aqueous hydrofluoric acid, potentially in combi-
Where a vacuum is used to induce fluid flow into the 
device, it may be necessary to provide means for creating a 
gas-tight seal around the edge of the device so that air is not 
drawn in through the microneedles at the biological barrier 
hole/microneedle shaft periphery. The attachment collar or 
adhesive material can be adapted to provide this function 
using techniques common to the those skilled in the art. One 
example is to design the attachment collar to function as a 
"suction-cup" and wet the interface of the skin and attach-
ment collar with water or another physiologically acceptable 
sealant. 
For sustained use, such as for taking sequential measure-
ments, the device preferably is adapted to be worn by the 
user, by including a securing means for securing the whole 
device to the user's body. For example, the device can be 
integrated into an adhesive patch or an elastic band, which 
may be worn, for example, around the user's arm or ankle. 
Feedback about Withdrawal 
In a preferred embodiment, the microneedle device 
includes a feedback means so that the user can determine 
whether withdrawal and/or sensing has been completed. 
Representative feedback means include a sound, a color 
(change) indicator, or a change in the position or shape of a 
reservmr. 
2. Manufacture of Microneedles 
nation with light, to etch channels into the silicon. By 
varying the doping concentration of the silicon wafer to be 
etched, the electrolytic potential during etching, the incident 
15 light intensity, and the electrolyte concentration, control 
over the ultimate pore structure can be achieved. The 
material not etched (i.e. the silicon remaining) forms the 
microneedles. This method has been used to produce irregu-
lar needle-type structures measuring tens of nanometers in 
20 width. 
(ii). Plasma Etching 
This process uses deep plasma etching of silicon to create 
microneedles with diameters on the order of 0.1 µm or 
25 
larger. Needles are patterned directly using photolithogra-
phy, rather than indirectly by controlling the voltage (as in 
electrochemical etching), thus providing greater control over 
the final microneedle geometry. 
In this process, an appropriate masking material (e.g., 
30 metal) is deposited onto a silicon wafer substrate and 
patterned into dots having the diameter of the desired 
microneedles. The wafer is then subjected to a carefully 
controlled plasma based on fluorine/oxygen chemistries to 
etch very deep, high aspect ratio trenches into the silicon. 
35 See, e.g., Jansen, et al., "The Black Silicon Method IV: The 
Fabrication of Three-Dimensional Structures in Silicon with 
High Aspect Ratios for Scanning Probe Microscopy and 
Other Applications," IEEE Proceedings of Micro Electro 
Mechanical Systems Conference, pp. 88-93 (1995). Those The microneedle devices are made by microfabrication 
processes, by creating small mechanical structures in silicon, 
metal, polymer, and other materials. These microfabrication 
processes are based on well-established methods used to 
make integrated circuits, electronic packages and other 
microelectronic devices, augmented by additional methods 
used in the field of micromachining. The microneedle 45 
devices can have dimensions as small as a few nanometers 
and can be mass-produced at low per-unit costs. 
40 regions protected by the metal mask remain and form the 
needles. This method is further described in Example 3 
below. 
(iii). Electroplating 
In this process, a metal layer is first evaporated onto a 
planar substrate. A layer of photoresist is then deposited onto 
the metal to form a patterned mold which leaves an exposed-
metal region in the shape of needles. By electroplating onto 
the exposed regions of the metal seed layer, the mold 
bounded by photoresist can be filled with electroplated 
a. Microfabrication Processes 
Microfabrication processes that may be used in making 
the microneedles disclosed herein include lithography; etch-
ing techniques, such as wet chemical, dry, and photoresist 
removal; thermal oxidation of silicon; electroplating and 
electro less plating; diffusion processes, such as boron, phos-
phorus, arsenic, and antimony diffusion; ion implantation; 
film deposition, such as evaporation (filament, electron 
beam, flash, and shadowing and step coverage), sputtering, 
chemical vapor deposition (CVD), epitaxy (vapor phase, 
liquid phase, and molecular beam), electroplating, screen 
printing, lamination, stereolithography, laser machining, and 
laser ablation (including projection ablation). See generally 
Jaeger, Introduction to Microelectronic Fabrication (Addi-
son-Wesley Publishing Co., Reading Mass. 1988); Runyan, 
et al., Semiconductor Integrated Circuit Processing Tech-
nology (Addison-Wesley Publishing Co., Reading Mass. 
1990); Proceedings of the IEEE Micro Electro Mechanical 
Systems Conference 1987-1998; Rai-Choudhury, ed., Hand-
book of Microlithography, Micromachining & Microfabri-
50 material. Finally, the substrate and photoresist mold are 
removed, leaving the finished microneedle array. The 
microneedles produced by this process generally have diam-
eters on the order of 1 µm or larger. See, e.g., Frazier, et al., 
"Two dimensional metallic microelectrode arrays for extra-
55 cellular stimulation and recording of neurons", IEEE Pro-
ceedings of the Micro Electro Mechanical Systems Confer-
ence, pp. 195-200 (1993). 
(iv). Other Processes 
Another method for forming microneedles made of sili-
60 con or other materials is to use microfabrication techniques 
such as photolithography, plasma etching, or laser ablation 
to make a mold form (A), transferring that mold form to 
other materials using standard mold transfer techniques, 
such as embossing or injection molding (B), and reproduc-
65 ing the shape of the original mold form (A) using the 
newly-created mold (B) to yield the final microneedles (C). 
Alternatively, the creation of the mold form (A) could be 
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skipped and the mold (B) could be microfabricated directly, 
which could then be used to create the final microneedles 
(C). 
Another method of forming solid silicon microneedles is 
by using epitaxial growth on silicon substrates, as is utilized 
by Containerless Research, Inc. (Evanston, Ill., USA) for its 
products. 
b. Hollow or Porous Microneedles 
12 
microneedle. Coatings can be formed either by deposition of 
a film or by oxidation of the silicon microneedles to a 
specific thickness, followed by removal of the interior 
silicon. Also, holes from the backside of the wafer to the 
underside of the hollow needles can be created using a 
front-to-backside infrared alignment followed by etching 
from the backside of the wafer. 
a. Silicon Microneedles 
One method for hollow needle fabrication is to replace the In a preferred embodiment, microneedles are made with 
pores or other pathways through which material may be 
transported. The following descriptions outline representa-
tive methods for fabricating either porous or hollow micron-
eedles. 
(i). Porous Microneedles 
10 solid mask used in the formation of solid needles by a mask 
that includes a solid shape with one or more interior regions 
of the solid shape removed. One example is a "donut-
shaped" mask. Using this type of mask, interior regions of 
the needle are etched simultaneously with their side walls. 
Rather than having a single, well-defined hole down the 
length of the needle, porous needles are filled with a network 
of channels or pores which allow conduction of fluid or 
energy through the needle shaft. It has been shown that by 
appropriate electrochemical oxidation of silicon, pore arrays 
with high aspect ratios and a range of different pore size 
regimes can be formed; these pore regimes are defined as (1) 
microporous regime with average pore dimensions less than 
15 Due to lateral etching of the inner side walls of the needle, 
this may not produce sufficiently sharp walls. In that case, 
two plasma etches may be used, one to form the outer walls 
of the microneedle (i.e., the 'standard' etch), and one to form 
the inner hollow core (which is an extremely anisotropic 
20 etch, such as in inductively-coupled-plasma "ICP" etch). For 
example, the ICP etch can be used to form the interior region 
of the needle followed by a second photolithography step 
and a standard etch to form the outer walls of the micron-2 nm, (2) mesoporous regime with average pore sizes of 
between 2 nm and 50 nm, and (3) macroporous regime with 
pores greater than 50 mm. The mesoporous and 25 
macroporous regimes are expected to be most useful for 
drug delivery. Two approaches to porous needles are gen-
erally available, either (a) the silicon wafer is first made 
porous and then etched as described above to form needles 
or (b) solid microneedles are etched and then rendered 30 
porous, for example, by means of electrochemical oxidation, 
such as by anodization of a silicon substrate in a hydrofluoric 
acid electrolyte. The size distribution of the etched porous 
structure is highly dependent on several variables, including 
doping kind and illumination conditions, as detailed in 35 
Lehmann, "Porous Silicon-A New Material for MEMS", 
IEEE Proceedings of the Micro Electro Mechanical Systems 
Conference, pp. 1-6 (1996). Porous polymer or metallic 
microneedles can be formed, for example, by micromolding 
a polymer containing a volatilizable or leachable material, 40 
such as a volatile salt, dispersed in the polymer or metal, and 
then volatilizing or leaching the dispersed material, leaving 
a porous polymer matrix in the shape of the microneedle. 
(ii). Hollow Needles 
Three-dimensional arrays of hollow microneedles can be 45 
fabricated, for example, using combinations of dry etching 
processes (Laermer, et al., "Bosch Deep Silicon Etching: 
Improving Uniformity and Etch Rate for Advanced MEMS 
Applications," Micro Electro Mechanical Systems, Orlando, 
Fla., USA, (Jan.17-21, 1999); Despontetal., "High-Aspect- 50 
Ratio, Ultrathick, Negative-Tone Near-UV Photoresist for 
MEMS", Proc. of IEEE lO'h Annuallnternational Workshop 
on MEMS, Nagoya, Japan, pp. 518-522 (Jan. 26-30, 1997)); 
micromold creation in lithographically-defined and/or laser 
ablated polymers and selective sidewall electroplating; or 55 
direct micromolding techniques using epoxy mold transfers. 
One or more distinct and continuous pathways are created 
through the interior ofmicroneedles. In a preferred embodi-
ment, the microneedle has a single annular pathway along 
the center axis of the microneedle. This pathway can be 60 
achieved by initially chemically or physically etching the 
holes in the material and then etching away microneedles 
around the hole. Alternatively, the microneedles and their 
holes can be made simultaneously or holes can be etched 
into existing microneedles. As another option, a microneedle 65 
form or mold can be made, then coated, and then etched 
away, leaving only the outer coating to form a hollow 
eedle. FIG. Sa represents a silicon wafer 82 with a patterned 
photoresist layer 84 on top of the wafer 82. The wafer 82 is 
anisotropically etched (FIG. Sb) to form a cavity 86 through 
its entire thickness (FIG. Sc). The wafer 82 is then coated 
with a chromium layer 88 followed by a second photoresist 
layer 90 patterned so as to cover the cavity 86 and form a 
circular mask for subsequent etching (FIG. Sd). The wafer 
82 is then etched by a standard etch to form the outer tapered 
walls 92 of the microneedle (FIG. Se). 
Alternatively, this structure can be achieved by substitut-
ing the chromium mask used for the solid microneedles 
described in Example 3 by a silicon nitride layer 94 on the 
silicon substrate 9S covered with chromium 96, deposited as 
shown in FIG. 6a and patterned as shown in FIG. 6b. Solid 
microneedles are then etched as described in Example 3 as 
shown FIG. 6c, the chromium 96 is stripped (FIG. 6d), and 
the silicon 9S is oxidized to form a thin layer of silicon 
dioxide 97 on all exposed silicon surfaces (FIG. 6e). The 
silicon nitride layer 94 prevents oxidation at the needle tip. 
The silicon nitride 94 is then stripped (FIG. 6j), leaving 
exposed silicon at the tip of the needle and oxide-covered 
silicon 97 everywhere else. The needle is then exposed to an 
ICP plasma which selectively etches the inner sidewalls of 
the silicon 9S in a highly anisotropic manner to form the 
interior hole of the needle (FIG. 6g). 
Another method uses the solid silicon needles described 
previously as 'forms' around which the actual needle struc-
tures are deposited. After deposition, the forms are etched 
away, yielding the hollow structures. Silica needles or metal 
needles can be formed using different methods. Silica 
needles can be formed by creating needle structures similar 
to the ICP needles described above prior to the oxidation 
described above. The wafers are then oxidized to a con-
trolled thickness, forming a layer on the shaft of the needle 
form which will eventually become the hollow microneedle. 
The silicon nitride is then stripped and the silicon core 
selectively etched away (e.g., in a wet alkaline solution) to 
form a hollow silica microneedle. 
In a preferred embodiment, an array of hollow silicon 
microtubes is made using deep reactive ion etching com-
bined with a modified black silicon process in a conven-
tional reactive ion etcher, as described in Example 4 below. 
First, arrays of circular holes are patterned through photo-
resist into Si02 , such as on a silicon wafer. Then the silicon 
US 7,344,499 Bl 
13 14 
electroplated onto the seed layer. The surrounding epoxy is 
then removed, leaving microtubes which each have an 
interior annular hole that extends through the base metal 
supporting the tubes. The rate and duration of electroplating 
is controlled in order to define the wall thickness and inner 
diameter of the microtubes. In one embodiment, this method 
was used to produce microtubes having a height of between 
about 150 and 250 µm, an outer diameter of between about 
40 and 120 µm, and an inner diameter of between about 30 
can be etched using deep reactive ion etching (DRIE) in an 
inductively coupled plasma (ICP) reactor to etch deep 
vertical holes. The photoresist is then removed. Next, a 
second photolithography step patterns the remaining Si02 
layer into circles concentric to the holes, leaving ring shaped 
oxide masks surrounding the holes. The photoresist is then 
removed and the silicon wafer again deep silicon etched, 
such that the holes are etched completely through the wafer 
(inside the Si02 ring) and simultaneously the silicon is 
etched around the Si02 ring leaving a cylinder. 10 and 110 µm (i.e., having a wall thickness of 10 µm). In a 
typical array, the microtubes have a tube center-to-center 
spacing of about 150 µm, but can vary depending on the 
desired needle density. 
This latter process can be varied to produce hollow, 
tapered microneedles. After an array of holes is fabricated as 
described above, the photoresist and Si02 layers are 
replaced with conformal DC sputtered chromium rings. The 
second ICP etch is replaced with a SF 6/02 plasma etch in a 15 
reactive ion etcher (RIE), which results in positively sloping 
outer sidewalls. Henry, et al., "Micromachined Needles for 
the Transdermal Delivery of Drugs," Micro Electro 
Mechanical Systems, Heidelberg, Germany, pp. 494-98 (Jan. 
26-29, 1998). 
A variation of this method is preferred for forming tapered 
microneedles. As described above, photolithography yields 
holes in the epoxy which have vertical sidewalls, such that 
the resulting shafts of the microneedles are straight, not 
tapered. This vertical sidewall limitation can be overcome 
by molding a preexisting 3D structure, i.e., a mold-insert. 
b. Metal Microneedles 
Metal needles can be formed by physical vapor deposition 
of appropriate metal layers on solid needle forms, which can 
20 The subsequent removal of the mold-insert leaves a mold 
which can be surface plated similarly to the holes produced 
by photolithography described above. 
be made of silicon using the techniques described above, or 
which can be formed using other standard mold techniques 25 
such as embossing or injection molding. The metals are 
selectively removed from the tips of the needles using 
electropolishing techniques, in which an applied anodic 
potential in an electrolytic solution will cause dissolution of 
metals more rapidly at sharp points, due to concentration of 30 
electric field lines at the sharp points. Once the underlying 
silicon needle forms have been exposed at the tips, the 
silicon is selectively etched away to form hollow metallic 
needle structures. This process could also be used to make 
hollow needles made from other materials by depositing a 35 
material other than metal on the needle forms and following 
the procedure described above. 
A preferred method of fabricating hollow metal micron-
eedles utilizes micromold plating techniques, which are 
described as follows and in Examples 5 and 6. In a method 40 
for making metal microtubes, which does not require dry 
silicon etching, a photo-defined mold first is first produced, 
for example, by spin casting a thick layer, typically 150 µm, 
of an epoxy (e.g., SU-8) onto a substrate that has been coated 
with a thin sacrificial layer, typically about 10 to 50 nm. 45 
Arrays of cylindrical holes are then photolithographically 
defined through the epoxy layer, which typically is about 
150 µm thick. (Despont, et al., "High-Aspect-Ratio, 
Ultrathick, Negative-Tone Near-UV Photoresist for 
MEMS," Proc. of IEEE lO'h Annuallnternational Workshop 50 
on MEMS, Nagoya, Japan, pp. 518-22 (Jan. 26-30, 1997)). 
The diameter of these cylindrical holes defines the outer 
diameter of the tubes. The upper surface of the substrate, the 
sacrificial layer, is then partially removed at the bottom of 
the cylindrical holes in the photoresist. The exact method 55 
chosen depends on the choice of substrate. For example, the 
process has been successfully performed on silicon and glass 
substrates (in which the upper surface is etched using 
isotropic wet or dry etching techniques) and copper-clad 
printed wiring board substrates. In the latter case, the copper 60 
laminate is selectively removed using wet etching. Then a 
seed layer, such as Ti/Cu/Ti (e.g., 30 mn/200 mn/30 nm), is 
conformally DC sputter-deposited onto the upper surface of 
the epoxy mold and onto the sidewalls of the cylindrical 
holes. The seed layer should be electrically isolated from the 65 
substrate. Subsequently, one or more electroplatable metals 
or alloys, such as Pd, Pt, Ni, NiFe, Au, Cu, or Ti, are 
Alternatively, non-vertical sidewalls can be produced 
directly in the polymeric mold into which electroplating will 
take place. For example, conventional photoresists known in 
the art can be exposed and developed in such as way as to 
have the surface immediately adjacent to the mask be wider 
than the other surface. Specialized greyscale photoresists in 
combination with greyscale masks can accomplish the same 
effect. Laser-ablated molds can also be made with tapered 
sidewalls, e.g., by optical adjustment of the beam (in the 
case of serial hole fabrication) or of the reticle or mold 
during ablation (in the case of projection ablation). 
To form hollow tapered microneedles, the mold-insert is 
an array of solid silicon microneedles, formed as described 
in Henry, et al., "Micromachined Needles for the Transder-
mal Delivery of Drugs," Micro Electro Mechanical Systems, 
Heidelberg, Germany, Jan. 26-29, pp. 494-98 (1998). First, 
a layer of a material, such as an epoxy (e.g., SU-8) or a 
polydimethylsiloxane ("PDMS"), is spin cast onto the array 
of silicon microneedles to completely blanket the entire 
array. The epoxy settles during pre-bake to create a planar 
surface above the silicon needle tips; the material is then 
fully pre-baked, photolithographically cross-linked, and 
post-baked. 
The upper surface of the epoxy is then etched away, for 
example with an 0 2 /CHF 3 plasma, until the needle tips are 
exposed, preferably leaving between about 1and5 µm of tip 
protruding from the epoxy. The silicon is then selectively 
removed, for example by using a SF 6 plasma or a HN03 /HF 
solution. The remaining epoxy micromold is the negative of 
the microneedles and has a small diameter hole where the tip 
of the microneedle formerly protruded. 
After the removal of the silicon, a seed layer, such as 
Ti-Cu-Ti, is conformally sputter-deposited onto the 
epoxy micromold. Following the same process sequence 
described for hollow metal microtubes, one or more elec-
troplatable metals or alloys (such as Ni, NiFe, Au, Pd, Pt, or 
Cu) are electroplated onto the seed layer. Finally, the epoxy 
is removed, for example by using an 0 2 /CHF 3 plasma, 
leaving an array of hollow metal microneedles. An advan-
tage of using PDMS in this application is that the micromold 
can be physically removed from the silicon mold insert by 
mechanical means, such as peeling, without damaging the 
silicon mold insert, thus allowing the silicon mold insert to 
be reused. Furthermore, the electroplated microneedles can 
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be removed from the PDMS mold by mechanical means, for 
example by peeling, thereby allowing the PDMS to also be 
reused. 
In a preferred embodiment, this method is used to produce 
microneedles having a height of between about 150 and 350 
µm, an outer diameter of between about 40 and 120 µm, and 
an inner diameter of between about 20 and 100 µm. In a 
typical array, the microneedles have a center-to-center spac-
ing of between about 150 and 300 µm, but can vary 
depending on the desired needle density. Tapered micron-
eedles preferably are 200 to 300 µm in height with a base 
diameter of 80 µm, a tip diameter of 30 µm, and a needle-
to-needle spacing of 150 µm. 
c. Silicon Dioxide Microneedles 
16 
A variety of analytes are routinely measured in the blood, 
lymph or other body fluids. Examples of typical analytes that 
can be measured include blood sugar (glucose), cholesterol, 
bilirubin, creatine, various metabolic enzymes, hemoglobin, 
heparin, hematocrit, vitamin K or other clotting factors, uric 
acid, carcinoembryonic antigen or other tumor antigens, and 
various reproductive hormones such as those associated with 
ovulation or pregnancy. Other substances or properties that 
would be desirable to detect include lactate (important for 
10 athletes), oxygen, pH, alcohol, tobacco metabolites, and 
illegal drugs (important for both medical diagnosis and law 
enforcement). 
Hollow microneedles formed of silicon dioxide can be 15 
In a preferred embodiment, interstitial fluids are removed 
from the dermis or epidermis across the stratum comeum to 
assay for glucose concentration, which is useful in aiding 
diabetics in determining their required insulin dose. made by oxidizing the surface of the silicon microneedle 
forms (as described above), rather than depositing a metal 
and then etching away the solid needle forms to leave the 
hollow silicon dioxide structures. This method is illustrated 
4. Using the Microneedle Device 
in FIGS. 7a-d. FIG. 7a shows an array 124 of needle forms 20 
126 with masks 128 on their tips. In FIG. 7b, the needle 
forms 126 have been coated with a layer 130 of metal, 
silicon dioxide or other material. FIG. 7c shows the coated 
needle forms 126 with the masks 128 removed. Finally, in 
FIG. 7d, the needle forms 126 have been etched away, 25 
leaving hollow needles 130 made of metal, silicon dioxide, 
The device is applied to the skin or other biological barrier 
at the site where the sample is to be collected or measured. 
Then, biological fluid, or a component thereof, is drawn into 
or through the pores or bores of the microneedles, and 
optionally collected in the collection chamber. Alternatively, 
where the microneedles function as the sensor, sensing 
occurs without transfer of biological fluid into a collection 
chamber. 
a. Feedback about Penetration of the Microneedles into 
the Tissue or other materials. 
In one embodiment, hollow, porous, or solid microneedles 
are provided with longitudinal grooves or other modifica- 30 
tions to the exterior surface of the microneedles. Grooves, 
The user of the microneedle device typically can deter-
mine if the microneedles have been properly inserted into 
the skin or other tissue through visual or tactile means, that 
is assessing whether the substrate has been pressed essen-
tially flush to the tissue surface. A coloring agent can be used 
to enhance the visual feedback by indicating a color change 
for example, should be useful in directing the flow of 
molecules along the outside of microneedles. 
d. Polymer Microneedles 
In a preferred method, polymeric microneedles are made 
using microfabricated molds. For example, the molds can be 
made as described herein and injection molding techniques 
can be applied to form the microneedles in the molds 
(Weber, et al., "Micromolding-a powerful tool for the large 
scale production of precise microstructures", Proc. SPIE-
International Soc. Optical Engineer. 2879: 156-67 (1996); 
Schift, et al., "Fabrication of replicated high precision insert 
elements for micro-optical bench arrangements" Proc. 
SPIE-International Soc. Optical Engineer. 3513: 122-34 
(1998)). Suitable molds can be formed, for example, from 
epoxy, silicon, or metal, using or adapting known microfab-
rication techniques. These micromolding techniques are 
preferred, as they can provide relatively less expensive 
replication, i.e. lower cost of mass production. In a preferred 
embodiment, the polymer is biodegradable. 
3. Biological Fluids for Withdrawal or Sensing 
The devices disclosed herein are useful in the transport of 
biological fluids from within or across a variety of biological 
barriers including the skin (or parts thereof); the blood-brain 
barrier; mucosa! tissue; blood vessels; lymphatic vessels; 
cell membranes; epithelial tissue; and endothelial tissue. The 
biological barriers can be in humans or other types of 
animals, as well as in plants, insects, or other organisms, 
including bacteria, yeast, fungi, and embryos. In preferred 
embodiments, biological fluids are withdrawn from skin, 
more preferably human skin, for minimally invasive diag-
nostic sensing. 
Biological fluids useful with the devices described herein 
include blood, lymph, interstitial fluid, and intracellular 
fluid. In a preferred embodiment, the biological fluid to be 
withdrawn or sensed is interstitial fluid. 
35 triggered by biological fluid filing the collection chamber. 
In a more complex embodiment, an electrical or chemical 
measurement is adapted to provide the feedback. For 
example, penetration can be determined by measuring a 
change in electrical resistance at the skin or other tissue, or 
40 a pH change. Alternately, needle-to-needle electrical resis-
tance can be measured. In a preferred embodiment, the 
microneedle device includes a disposable cartridge contain-
ing the microneedles. In these devices, an LED (e.g., green 
light/red light) or liquid crystal display can be provided with 
45 the reusable portion or the device. 
b. Initiating and Controlling Fluid Withdrawal 
In a preferred embodiment, the microneedle device is 
capable of transporting molecules across or from the tissue 
at a useful rate. That rate will, of course, depend on the 
50 particular application. For assaying blood glucose, for 
example, the device preferably withdraws at least between 
about 5 and 10 µI of interstitial fluid, preferably in about a 
minute or less time. For other applications, it may be 
desirable to apply the device to the barrier for several hours 
55 or more in order to monitor the changing blood plasma level 
of a particular analyte, such as an exogenous drug or 
hormone level, for example on a real-time basis or to obtain 
a time-averaged value. 
The rate of withdrawal can be controlled by altering one 
60 or more of several design variables. For example, the 
amount of material flowing through the needles can be 
controlled by manipulating the volumetric through-capacity 
of a single device array, for example, by using more or fewer 
microneedles, by increasing or decreasing the number or 
65 diameter of the bores in the microneedles, by filling at least 
some of the microneedle bores with a diffusion-limiting 
material, or by varying the driving force applied to the 
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biological fluid. It is preferred, however, to simplify the 
manufacturing process by limiting the needle design to two 
or three "sizes" of microneedle arrays to accommodate, for 
example small, medium, and large volumetric flows, for 
which the withdrawal rate is controlled by other means. 
The flow of biological fluid from the tissue through the 
microneedle and into the collection chamber or into contact 
with the sensors occurs due to capillary action, diffusion, or 
is induced using conventional mechanical pumps or nonme-
chanical driving forces, such as electroosmosis or electro-
phoresis, thermal gradients, or convection. For example, in 
electroosmosis, electrodes are positioned on the biological 
barrier surface, on one or more microneedles, and/or on the 
substrate adjacent the needles, to create a convective flow 
which carries charged ionic species and/or neutral molecules 
toward and/or through at least one of the microneedles. 
Transportation of molecules through the microneedles can 
be controlled or monitored using, for example, various 
combinations of semi-permeable membranes, valves, 
pumps, sensors, actuators, and microprocessors. These com-
ponents can be produced using standard manufacturing or 
microfabrication techniques. Actuators that may be useful 
with the microneedle devices disclosed herein include 
micropumps, microvalves, and positioners. 
In a preferred embodiment, the microneedle device is 
used in combination with another mechanism that enhances 
the permeability of the biological barrier, for example by 
increasing cell membrane disruption, using electric fields, 
ultrasound, chemical enhancers, vacuum, viruses, pH, heat, 
and/or light. Chemical and/or physical enhancers can be 
applied to the biological barrier at the site of insertion of the 
device before or during the withdrawal of the device, for 
example, to draw analyte closer to the skin surface. 
(i). Bulk Flow Extraction 
18 
engineered to create a volume expansion/pressure reduction 
in the collection chamber to draw biological fluid to be 
drawn into the collection chamber. 
In a preferred embodiment, withdrawal is conducted 
using a microneedle device fitted to a Luer-Lock syringe or 
similar conventionally-used devices that currently uses 
hypodermic needles in the barrier penetration method. 
(ii). Diffusion-Based Extraction 
One preferred embodiment uses diffusion to move the 
10 analyte fluid into the fluid collection chamber. A micron-
eedle device using this method generally includes micron-
eedle bores or pores, and/or a fluid collection chamber, that 
are filled with a diffusion medium, such as water, a saline 
solution, or a gel, which is physiologically compatible with 
15 the biological barrier tissue. Once the needle is inserted into 
the biological barrier (e.g., the skin), the diffusion medium 
contacts the biological fluid. Typically, the diffusion medium 
in the microneedles initially contains none of the analyte to 
be measured; therefore, analyte at a higher concentration in 
20 the biological fluid diffuses into the diffusion medium in the 
microneedle until a detectable level of analyte in collected or 
measured. This should be achieved rapidly due to the very 
small size/length of the microneedles, thereby providing an 
analyte concentration for sensing that is rapidly response to 
25 that in the tissue. 
(iii). Hybrid Bulk Flow/Diffusion 
In another embodiment, the microneedle device is 
designed to employ a combination of forces to drive the 
analyte into the collection chamber. A preferred hybrid 
30 design includes the preferred bulk flow microneedle device 
described above, but with two primary differences. First, the 
fluid collection chamber has no one-way valve and contains 
a fluid diffusion medium, preferably physiological saline. 
Second, a temporary barrier is interposed between the fluid 
35 collection chamber and the base of the microneedles. The A preferred microneedle device is shown in FIG. 2 and 
described above. Microneedle device 20 preferably is oper-
ated as follows. After or simultaneously with the insertion of 
device 20 into, for example, the skin, manual pressure is 
applied to elastic cap 22 so as to deform (compress) it and 
reduce the interior volume of elastic cap 22 and fluid 
collection chamber 16. The deformation causes gas within 
the cap and chamber to be purged from the device via 
one-way valve 24. As elastic cap 22 returns to its unde-
formed (uncompressed) shape, pressure is reduced within 
the interior volume, creating a pressure differential or 
vacuum, which causes the interstitial fluid, to be drawn 
through the microneedles 14 and into fluid collection cham-
ber 16, until the pressure is equalized. Once in the collection 
chamber 16, the fluid sample can be analyzed by withdraw-
ing device 20 from the skin, again depressing elastic cap 22, 50 
to force the sample out of the chamber either through the 
microneedles 14 or one-way valve 24, and, for example, 
onto a diagnostic strip or into a container adapted for the 
particular analytical method to be employed. 
temporary barrier can be a fracturable membrane, mechani-
cal gate, or other means for containing the diffusion medium 
within the device until the barrier is broken or removed at a 
selected time to permit flow of molecules between the 
40 microneedles and fluid collection chamber. 
In a preferred embodiment, the temporary barrier is an 
easily fracturable membrane. The device can function as 
follows: The microneedles first are inserted into the skin of 
the user. Then the user depresses the elastic cap, causing the 
45 fluid diffusion medium to fracture the membrane and fill the 
bores or pores of the microneedles and contact the biological 
fluid. After the user releases the elastic cap, it partially or 
fully returns to its undeformed shape, reducing the pressure 
in the interior and causing a mixture of the biological fluid 
and diffusion medium to be drawn through the microneedles 
and into fluid collection chamber. Once bulk fluid flow 
ceases, diffusion may continue until the concentration of 
biological fluid or analyte equilibrates. The mixture can be 
assayed as described herein, considering the dilution effect 
induced by the presence of the diffusion medium. Other spring means can be adapted to cause a change in 55 
the volume, and thus internal pressure, of the collection 
chamber. For example, the fluid collection chamber can be 
adapted to have a movable, rigid top with fixed, rigid side 
walls, wherein the interface between the walls and top form 
a gas-tight seal (such as by using a gasket). The volume of 60 
the piston-like apparatus can be expanding by activating one 
or more compressed springs to move the top of the chamber 
as desired, thereby reducing the pressure in the collection 
chamber. 
Any of these embodiments of the microneedle device can 
be adapted to function a series of micro-assays (e.g., as can 
be provided with an electronics package) or single assays 
(e.g., standard glucose strips). 
e. Multi-Cartridge Microneedle Device 
A modification of the disposable, single use microneedle 
device utilizes a reusable portion providing the withdrawal 
force (e.g., suction) or electronics package in combination 
with a cartridge containing one or more, preferably a plu-
In an alternative embodiment, withdrawal can be initiated 
by activating an osmotic pump, as described, for example, in 
U.S. Pat. No. 4,320,758 to Eckenhoff, which has been 
65 rality, of single-use, disposable microneedle devices for 
collection and/or sensing. For example, the cartridge can be 
a circular disk having 10 or 12 microneedle arrays connected 
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to a single-assay element, wherein the cartridge can be 
loaded into and unloaded from the reusable portion. The 
triggering device can, for example, be designed to move a 
new microneedle array into position, withdraw or sense the 
sample of biological fluid, and then eject or immobilize the 
used microneedle array. This type of reusable triggering 
device also can include a power source, such as a battery, 
used to operate a built-in measurement device, for example, 
for analyte measurement of interstitial fluids. 
In one embodiment, the devices are provided in a multi-
pack (e.g., six or twelve pack) form of complete devices, that 
is, each device is fully sufficient for use. Individual devices 
can be separated as needed for each sensing measurement. 
The present invention will be further understood with 
reference to the following non-limiting examples. 
EXAMPLE 1 
Transport of Molecules Through Microneedles 
Inserted into Skin 
Studies were performed to demonstrate transport of mol-
ecules using either solid silicon microneedles or using 
hollow silicon microneedles. Transport was measured across 
human cadaver epidermis in vitro using Franz diffusion 
chambers at 37° C. using methods described in Henry, et al., 
"Micro fabricated microneedles: A novel method to increase 
transdermal drug delivery" J. Pharm. Sci. 87:922-25 (1998). 
Removal of calcein was measured. Removal refers to the 
ability to transport calcein from the viable epidermis side of 
the epidermis to the stratum corneum side. This is the 
direction of transport associated with removing from the 
body compounds found in the body, such as glucose. Other 
compounds were tested for delivery only. 
Compound 
Insulin 
10 delivery 
Bovine serum 
albumin 
delivery 
20 
TABLE I-continued 
Effect of Microneedles on Permeability 
of Skin to Drugs (cm/hr) 
Solid needles 
No Solid needles inserted and 
needles inserted removed 
1 x 10-4 1 x 10-2 
9 x 10-4 8 x 10-3 
** means that the transport was below the detection limit. 
15 n.a. means tbat tbe data are not available. 
EXAMPLE 2 
Hollow 
needles 
inserted 
n.a. 
9 x 10-2 
20 
Flow of Water Through Hollow Microneedles 
To demonstrate that fluid can be forced through hollow 
microneedles at meaningful rates, the flow rate of water 
through a microneedle array was measures as a function of 
25 
pressure. The array used contained 100 hollow silicon 
microneedles having an inner diameter of 50 µm and an 
outer diameter of 80 µm. The results, which are shown in 
Table 2, demonstrate that significant flow rates of water 
through microneedles can be achieved at modest pressures. 
30 
The measured flow rates are comparable to flow rates 
through hypodermic needles attached to syringes. 
TABLE 2 
Flow Rate of Water Through Hollow Silicon Microneedles 
35 As a Function of Applied Pressure 
In all cases shown in Table 1, transport of these com-
pounds across skin occurred at levels below our detection 
limit when no needles were inserted into the skin. When 
solid microneedles were inserted into the skin and left in 
place, large skin permeabilities were measured, indicating 40 
that the microneedles had created pathways for transport 
across the skin. Furthermore, in all cases, when solid 
microneedles were inserted into the skin and then removed, 
even greater skin permeabilities resulted. Finally, when 
hollow microneedles were inserted into the skin and left in 45 
place, still greater skin permeabilities resulted for those 
compounds tested. These studies show that microneedles 
can dramatically increase skin permeability and can thereby 
increase transport of a number of different compounds 
across the skin. It also shows that when solid microneedles 50 
Pressure (psi) Flow rate (ml/min) 
1.0 16 
1.5 24 
2.0 31 
2.5 38 
3.0 45 
EXAMPLE 3 
Fabrication of Solid Silicon Microneedles 
A chromium masking material was deposited onto silicon 
wafers and patterned into dots having a diameter approxi-
mately equal to the base of the desired microneedles. The 
wafers were then loaded into a reactive ion etcher and 
subjected to a carefully controlled plasma based on fluorine/ 
oxygen chemistries to etch very deep, high aspect ratio 
are used, a preferred embodiment involves inserting and 
then removing microneedles, rather than leaving them in 
place. It also shows that using hollow microneedles are a 
preferred embodiment over the use of solid microneedles. 
Compound 
Calcein 
delivery 
Calcein 
removal 
TABLE 1 
Effect of Microneedles on Permeability 
of Skin to Drugs (cm/hr) 
Solid needles 
No Solid needles inserted and 
needles inserted removed 
4 x 10-3 1 x 10-2 
2 x 10-3 1 x 10-2 
Hollow 
needles 
inserted 
1x10-1 
n.a. 
55 valleys into the silicon. Those regions protected by the metal 
mask remain and form the microneedles. 
60 
65 
<100>-oriented, prime grade, 450-550 µm thick, 10-15 
Q-cm silicon wafers (Nova Electronic Materials Inc., Rich-
ardson, Tex.) were used as the starting material. The wafers 
were cleaned in a solution of 5 parts by volume deionized 
water, 1 part 30% hydrogen peroxide, and 1 part 30% 
ammonium hydroxide (J. T. Baker, Phillipsburg, N.J.) at 
approximately 80° C. for 15 minutes, and then dried in an 
oven (Blue M Electric, Watertown, Wis.) at 150° C. for 10 
minutes. Approximately 1000 A of chromium (Mat-Vac 
Technology, Flagler Beach, Fla.) was deposited onto the 
wafers using a DC-sputterer (601 Sputtering System, CVC 
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Products, Rochester, N.Y.). The chromium layer was pat-
terned into 20 by 20 arrays of 80 µm diameter dots with 150 
µm center-to-center spacing using the lithographic process 
described below. 
A layer of photosensitive material (1827 photoresist, 5 
Shipley, Marlborough, Mass.) was deposited onto the chro-
mium layer covering the silicon wafers. A standard litho-
graphic mask (Telic, Santa Monica, Calif.) bearing the 
appropriate dot array pattern was positioned on top of the 
photoresist layer. The wafer and photoresist were then 10 
exposed to ultraviolet (UV) light through the mask by means 
of an optical mask aligner (Hybralign Series 500, Optical 
Associates, Inc., Milpitas, Calif.). The exposed photoresist 
was removed by soaking the wafers in a liquid developer 
(354 developer, Shipley, Marlborough, Mass.) leaving the 15 
desired dot array of photoresist on the chromium layer. 
Subsequently, the wafers were dipped into a chromium 
etchant (CR-75; Cyanteck Fremont, Calif.), which etched 
the chromium that had been exposed during the photolithog-
raphy step, leaving dot arrays of chromium (covered with 20 
photoresist) on the surface of the silicon wafer. The photo-
resist still present on the chromium dots formed the masks 
needed for fabrication of the microneedles, described below. 
The microneedles were fabricated using a reactive ion 
etching techniques based on the Black Silicon Method 25 
developed at the University ofTwente. The patterned wafers 
were etched in a reactive ion etcher (700 series wafer/batch 
Plasma Processing System, Plasma Therm, St. Petersburg, 
Fla.) with means for ensuring good thermal contact between 
the wafers and the underlying platen (Apiezon N, K. J. 30 
Lesker, Clairton, Pa.). The wafers were etched using the 
following gases and conditions: SF 6 (20 standard cubic 
centimeters per minute) and 0 2 (15 standard cubic centime-
ters per minute) at a pressure of 150 mTorr and a power of 
150 W for a run time of approximately 250 minutes. These 35 
conditions caused both deep vertical etching and slight 
lateral underetching. By controlling the ratio of flow rates of 
the SF 6 and 0 2 gases used to form the plasma, the aspect 
ratio of the microneedles could be adjusted. The regions 
protected by the chromium masks remained and formed the 40 
microneedles. Etching was allowed to proceed until the 
masks fell off due to underetching, resulting in an array of 
sharp silicon spikes. 
22 
(FIG. Sc). The photoresist 134 was then removed and the 
wafer 13S was again deep silicon etched, while simulta-
neously the holes 140 were etched completely through the 
wafer 13S (inside the Si02 ring) and the silicon was etched 
around the Si02 ring 13S leaving a cylinder 142 (FIG. Sd). 
The resulting tubes were 150 µm in height, with an outer 
diameter of 80 µm, an inner diameter of 40 µm, and a tube 
center-to-center spacing of 300 µm. 
EXAMPLE 5 
Micromold Fabrication of Metal Microtubes 
Hollow metal microtubes were prepared without dry 
silicon etching, using a thick, photo-defined mold of epoxy. 
The sequences are illustrated in FIGS. 9a-e. First, a thick 
layer ofSU-8 epoxy 144 was spin cast onto a silicon or glass 
substrate 146 that had been coated with 30 nm of titanium 
14S, the sacrificial layer. Arrays of cylindrical holes 149 
were then photolithographically defined through an epoxy 
layer 144, typically 150 µm thick (FIG. 9a). The sacrificial 
layer 14S at the bottom of the cylindrical holes 149 then was 
partially removed using a wet etching solution containing 
hydrofluoric acid and water (FIG. 9b). A seed layer of 
Ti/Cu/Ti (30 nm/200 nm/30 nm) 139 was then conformally 
DC sputter-deposited onto the upper surface of the epoxy 
mold and onto the sidewalls of the cylindrical holes 149 
(FIG. 9c). As shown in FIG. 9c, the seed layer 139 was 
electrically isolated from the substrate 146. Subsequently, 
NiFe 145 was electroplated onto the seed layer 139 (FIG. 
9d), and the epoxy 144, the substrate 146, and the sacrificial 
layer 14S were removed, leaving the electroplated structure 
(microtubes) consisting of the Ti/Cu/Ti seed layer 139 and 
the NiFe layer 145 (FIG. 9e). The resulting microtubes are 
200 µm in height with an outer diameter of 80 µm, an inner 
diameter of 60 µm, and a tube center-to-center spacing of 
150 µm. The holes in the interior of the microtubes extend 
through the base metal supporting the tubes. 
EXAMPLE 6 
Micromold Fabrication of Tapered Microneedles 
A micromold having tapered walls was fabricated by 
EXAMPLE 4 
Fabrication of Silicon Microtubes 
45 molding a preexisting 3-D array of microneedles, i.e. the 
mold-insert, and subsequently removing the mold insert. 
The micromold was then surface plated in a manner similar 
to that for the microtubes described in Example 5. The 
fabrication sequence is illustrated in FIGS. lOa-d. 
First, an array of solid silicon microneedles 50 were 
prepared as described in Henry, et al., "Micromachined 
Needles for the Transdermal Delivery of Drugs," Micro 
Electro Mechanical Systems, Heidelberg, Germany, pp. 494-
98 (Jan. 26-29, 1998). Then, a layer of epoxy 52 (SU-8) was 
Three-dimensional arrays of microtubes were fabricated 
from silicon, using deep reactive ion etching combined with 50 
a modified black silicon process in a conventional reactive 
ion etcher. The fabrication process is illustrated in FIGS. 
Sa-d. First, arrays of 40 µm diameter circular holes 132 were 
patterned through photoresist 134 into a 1 µm thick Si02 
layer 136 on a two inch silicon wafer 13S (FIG. Sa). The 
wafer 13S was then etched using deep reactive ion etching 
(DRIE) (Laermer, et al., "Bosch Deep Silicon Etching: 
Improving Uniformity and Etch Rate for Advanced MEMS 
Applications," Micro Electro Mechanical Systems, Orlando, 
Fla., USA (Jan. 17-21, 1999)) in an inductively coupled 60 
plasma (ICP) reactor to etch deep vertical holes 140. The 
deep silicon etch was stopped after the holes 140 reached 
approximately 200 µm deep into the silicon substrate 13S 
(FIG. Sb). The photoresist 134 was removed, and a second 
photolithography step was used to pattern the remaining 
Si0
2 
layer 136 into circles concentric to the holes, thus 
leaving ring shaped oxide masks 134 surrounding the holes 
55 spin cast onto the microneedle array to completely blanket 
the array (FIG. lOa). The epoxy 52 settled during pre-bake 
to create a planar surface above the tips of the microneedles 
50. The epoxy 52 was then fully pre-baked, photolitho-
graphically cross-linked, and post-baked. 
Then, the upper surface of the epoxy 52 was etched away 
using an 0iCHF3 plasma until approximately 1 to 2 µm of 
the needle tips 51 were exposed, protruding from the epoxy 
52 (FIG. lOb). The silicon was then selectively removed by 
using a SF6 plasma (FIG. lOc). The remaining epoxy mold 
65 52 provided a negative of the microneedles with a small 
diameter hole where the tip of the silicon needle protruded. 
After the removal of the silicon, a seed layer of Ti-Cu-Ti 
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54 was conformally sputter-deposited onto the top and 
sidewalls of the epoxy micromold 52. Following the same 
process sequence as described in Example 5, NiFe 55 was 
then electroplated onto the seed layer 54. Finally, the epoxy 
24 
metal layer 80 on top of it (FIG. 12e). The polymer layer 70 
is then removed to form the microneedles 78/80 (FIG. 12.1). 
Publications cited herein and the material for which they 
are cited are specifically incorporated by reference. Nothing 
herein is to be construed as an admission that the invention 
is not entitled to antedate such disclosure by virtue of prior 
invention. 
Modifications and variations of the methods and devices 
described herein will be obvious to those skilled in the art 
52 was removed using an 0iCHF3 plasma, leaving a 
released structure of hollow metal microneedles 56 formed 
ofNiFe 55 layer and Ti-Cu-Ti 54 seed layer (FIG. lOd). 
The microneedles were made in a 20x20 array, and were 150 
µm in height with a base diameter of 80 µm, a tip diameter 
of 10 µm, and a needle-to-needle spacing of 150 µm. 10 from the foregoing detailed description. Such modifications 
and variations are intended to come within the scope of the 
appended claims. 
Micromold-based microneedles also have been success-
fully manufactured using a process in which the epoxy mold 
material was replaced with PDMS. In this case, it was 
possible to remove the mold from the mold insert, as well as 
the microneedles from the mold, using only physical tech- 15 
niques such as peeling. This approach advantageously 
requires no dry etching and allows one to reuse both the 
mold and the mold insert. 
EXAMPLE 7 
Micromold Fabrication of Tapered Microneedles 
Using Laser-Formed Molds 
20 
A micromold having tapered walls was fabricated by use 25 
of laser ablation techniques, as shown in FIGS. lla-d. A 
laser-ablatable polymer sheet 60 such as KAPTON™ poly-
imide approximately 150 microns in thickness was option-
ally laminated to a thin (10-30 µm) metal sheet 62 such as 
titanium (FIG. lla). A tapered hole 64 was formed in the 30 
metal/polymer laminate 60/62 using a laser technique such 
We claim: 
1. A device for collecting a sample of a biological fluid 
comprising: 
one or more hollow or porous microneedles, each having 
a base end and a tip; 
a substrate to which the base end is attached or integrated; 
and 
at least one collection chamber suitable for collecting said 
sample of said biological fluid, said collection chamber 
selectably in fluid communication with the base end, 
and wherein said collection chamber comprises a one-
way valve and an upper portion which is formed of a 
deformable material. 
2. A device for collecting a sample of a biological fluid 
comprising: 
one or more hollow or porous microneedles, each having 
a base end and a tip; 
a substrate to which the base end is attached or integrated; 
and 
at least one collection chamber suitable for collecting said 
sample of said biological fluid, wherein said collection 
chamber is selectably in fluid communication with the 
base end, and comprises a plurality of compartments. 
3. The device of claim 2, further comprising a means for 
inducing transport of a biological fluid or component thereof 
into the collection chamber. 
4. The device of claim 3 wherein the pressure within the 
collection chamber can selectively be reduced. 
5. The device of claim 4 wherein the pressure reduction is 
induced by expanding the internal volume of the collection 
chamber. 
6. The device of claim 5 wherein the collection chamber 
as excimer laser ablation (FIG. llb ). The entry hole of the 
laser spot was on the metal side 62, and a through hole was 
made through both the metal sheet and the polymer film. The 
through hole 64 was tapered in combination with either 35 
defocusing or appropriate substrate motion to create a taper 
such that the wide end of the hole 64 (typically 40-50 µm) 
was on the metal side 62 and the narrow end of the hole 64 
(typically 10-20 µm) was on the polymer 60 side. A thin 
layer of metal 66, e.g. titanium, of thickness 0.1 micron was 40 
then deposited, e.g., using a sputter-deposition technique, in 
such a way that the metal 66 deposited on the metal film side 
and coated the polymer sidewalls, but did not coat the 
polymer 60 side of the laminate (FIG. llc). Electrodeposi-
tion of metal 68, e.g., gold, to a thickness of 1 to 5 µm was 
then performed on the titanium-coated metal surface 66, and 
polymer sidewalls curved section of 60 next to 64. Finally, 
the polymer 60 was removed, using e.g. an oxygen plasma, 
45 is a standard or Luer-lock syringe. 
to form the completed microneedles (FIG. lld). 
Alternate polymer removal methods, such as thermal, 50 
solvent, aqueous, or photo-degradation followed by solvent 
or aqueous removal, are also possible if the polymer material 
is chosen appropriately (e.g., a photoresist resin). 
EXAMPLE 8 55 
Formation of Microneedles by Embossing 
Formation of a microneedle by embossing is shown in 
FIGS. 12a:f A polymeric layer 70 (FIG. 12a) is embossed 60 
by a solid microneedle or microneedle array 72 (FIG. 12b). 
The array 72 is removed (FIG. 12c), and the layer 70 is 
etched from the non-embossed side 74 until the embossed 
cavity 76 is exposed (FIG. 12d). A metallic layer 78 is then 
deposited on the embossed side and the sidewalls, but not on 65 
the non-embossed side 74 (FIG. 12e). This layer 78 is 
optionally thickened by electrodeposition of an additional 
7. The device of claim 3 wherein the collection chamber 
comprises an upper portion which is formed of a material 
which is deformable. 
8. The device of claim 7 wherein the collection chamber 
comprises a one-way valve. 
9. The device of claim 4 wherein the means for inducing 
transport comprises a plunger movably secured to the sub-
strate, wherein the plunger can deform the collection cham-
ber. 
10. The device of claim 2, comprising a three dimensional 
array of microneedles. 
11. The device of claim 2, further comprising an adhesive 
material for securing the device to a biological barrier 
surface during fluid withdrawal or sensing. 
12. The device of claim 2, further comprising a means for 
controlling flow through the microneedle. 
13. The device of claim 12 wherein the means for 
controlling flow is a fracturable or removable barrier which 
is interposed between the collection chamber and base of the 
microneedle. 
14. The device of claim 2, further comprising a sensor in 
communication with the collection chamber. 
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15. The device of claim 2, wherein the collection chamber 
is adapted to receive and use glucose strips. 
16. The device of claim 2, wherein the microneedle is 
hollow and comprises at least one opening in the side of the 
microneedle. 
17. The device of claim 2, wherein the microneedle has a 
hollow bore containing a material to modulate the flow of 
biological fluid through the microneedles into the collection 
chamber. 
18. The device of claim 2, wherein the microneedle is 10 
hollow. 
26 
27. The method of claim 25, wherein triggering the 
transport is effected by a pressure gradient in which the 
pressure within the microneedles and/or collection chamber 
is less than the pressure of the biological fluid adjacent the 
tip of the microneedle. 
28. The method of claim 25 wherein the analyte to be 
collected or sensed is selected from the group consisting of 
glucose, cholesterol, bilirubin, creatine, metabolic enzymes, 
hemoglobin, heparin, clotting factors, uric acid, tumor anti-
gens, reproductive hormones, oxygen, pH, alcohol, tobacco 
metabolites, and illegal drugs. 
19. The device of claim 2, wherein the microneedle is 
perpendicular to a surface of the substrate. 
20. The device of claim 2, wherein the microneedle has a 
diameter between about 40 and 120 µm. 
29. The method of claim 25, wherein the analyte is 
glucose, and wherein the biological barrier is human skin. 
30. The device of claim 24, wherein the microneedle 
15 consists essentially of a metal. 
21. A device for collecting a sample of a biological fluid 
comprising: 
one or more hollow or porous microneedles, each having 
a base end and a tip; 
a substrate to which the base end is attached or integrated; 20 
at least one collection chamber suitable for collecting said 
sample of said biological fluid, said collection chamber 
selectably in fluid communication with the base end; 
and 
a fracturable or removable barrier for controlling flow 25 
through the microneedle, said barrier interposed 
between the collection chamber and base of the micron-
eedle. 
22. A device for collecting a sample of a biological fluid 
comprising: 
one or more hollow or porous microneedles, each having 
a base end and a tip; 
a substrate to which the base end is attached or integrated; 
and 
30 
at least one collection chamber suitable for collecting said 35 
sample of said biological fluid, said collection chamber 
selectably in fluid communication with the base end, 
wherein the one or more microneedles has a hollow bore 
containing a material to modulate the flow of biological 
fluid through the microneedles into the collection 40 
chamber. 
23. The device of any one of claims 1-22, wherein the one 
31. A device for sensing an analyte in a biological fluid 
comprising: 
one or more microneedles, each having a base end and a 
tip, a length between about 500 µm and 1 mm and a 
width between about 1 µm and 500 µm, and comprising 
a metal; 
a substrate to which the base of the microneedle is 
attached or integrated; and 
at least one sensor which is selectably in fluid commu-
nication with the microneedle. 
32. A device for sensing an analyte in a biological fluid 
comprising: 
one or more microneedles, each having a base end and a 
tip; 
a substrate to which the base of the microneedle is 
attached or integrated; and 
at least one sensor which is selectably in fluid commu-
nication with the microneedle, 
wherein the one or more microneedles has a hollow bore 
containing a material to modulate the flow of biological 
fluid through the microneedles into a collection cham-
ber. 
33. The device of claim 32, wherein the sensor comprises: 
a chemical or biochemical agent that react with the 
analyte, and 
electrochemical or optical transducers which measure the 
reaction of the agent and the analyte. or more microneedles each has a length between about 500 
µm and 1 mm and a width between about 1 µm and 500 µm. 
24. A device for collecting a sample of a biological fluid 
comprising: 
one or more hollow or porous microneedles, each having 
34. The device of claim 33 wherein the agent is an enzyme 
45 selected from the croup consisting of glucose oxidase, 
glucose dehydrogenase, and combinations thereof. 
a base end and a tip, a length between 500 µm and 1 
mm and a width between about 1 µm and 500 µm, and 
comprising a metal; 
a substrate to which the base end is attached or integrated; 
and 
at least one collection chamber suitable for collecting said 
sample of said biological fluid, said collection chamber 
selectably in fluid communication with the base end. 
25. A method for collecting a sample of a biological fluid 
or analyte therein, comprising the steps: 
providing the device of any one of claims 1-24; 
inserting said one or more microneedles of the device into 
a biological barrier comprising biological fluid; and 
triggering the transport of a quantity of the biological fluid 
or analyte therein through said one or more micron-
eedles and into the collection chamber. 
35. The device of claim 32, further comprising an elec-
tronics package in communication with the sensor. 
36. The device of claim 32, wherein the microneedle 
50 
comprises a metal. 
37. The device of claim 36, wherein the microneedle 
consists essentially of a metal. 
38. The device of claim 32, wherein the microneedle is 
55 hollow. 
60 
39. The device of claim 32, wherein the microneedle is 
perpendicular to a surface of the substrate. 
40. A device for sensing an analyte in a biological fluid 
comprising: 
one or more microneedles, each having a base end and a 
tip; and 
a substrate to which the base of the microneedle is 
26. The method of claim 25, wherein triggering the 
transport is effected by capillary action, diffusion, mechani- 65 
cal pumps, electroosmosis, electrophoresis, convection, or 
combinations thereof. 
attached or integrated, wherein at least one of the 
microneedles is or comprises a sensor, and wherein the 
one or more microneedles has a hollow bore containing 
a material to modulate the flow of biological fluid 
through the microneedles into a collection chamber. 
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41. The device of claim 40, wherein the sensor comprises: 
a chemical or biochemical agent that reacts with the 
analyte, and 
electrochemical or optical transducers which measure the 
reaction of the agent and the analyte. 
42. The device of claim 40, further comprising an elec-
tronics package in communication with the sensor. 
43. A method for sensing an analyte in a biological fluid, 
comprising the steps: 
providing the device of claim 31, 32, or 40; 
inserting said one or more microneedles into a biological 
barrier comprising said biological fluid which contains 
said analyte; and 
contacting the sensor with the biological fluid, thereby 
sensing the analyte. 
44. The method of claim 43 wherein the device further 
comprises: 
at least one collection chamber which is selectably in fluid 
connection with the base end of the microneedle, and 
a means for inducing transport of the biological fluid or 
the analyte therein into the collection chamber, 
28 
wherein, after the microneedles are inserted, the means 
for inducing is triggered to draw the biological fluid or 
the analyte therein through the microneedles and into 
the collection chamber. 
45. The method of claim 44 wherein the means for 
inducing utilizes a pressure gradient in which the pressure 
within the microneedles and for collection chamber is less 
than the pressure of the biological fluid adjacent the tip of 
the microneedle. 
10 46. The method of claim 45 wherein the pressure gradient 
is created by increasing the volume within the collection 
chamber. 
47. The method of claim 43 wherein the analyte to be 
collected or sensed is selected from the group consisting of 
15 glucose, cholesterol, bilirubin, creatine, metabolic enzymes, 
hemoglobin, heparin, clotting factors, uric acid, tumor anti-
gens, reproductive hormones, oxygen, pH, alcohol, tobacco 
metabolites, and illegal drugs. 
48. The method of claim 43, wherein the analyte is 
20 glucose, and wherein the biological barrier is human skin. 
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